Last deal

$82M

Amount

Series A

Stage

29.02.2024

Date

3

all rounds

$89M

Total amount

date founded

Financing round

General

About Company
Ryne Biotechnology develops therapies for neurodegenerative movement disorders.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2022

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The Cambridge-based biotech company, founded in 2022, is advancing neuron replacement therapies using induced pluripotent stem cell (iPSC) technology. Their lead program, RNDP-001, targets Parkinson's Disease and consists of cryopreserved iPSC dopamine neuron progenitor that can be manufactured and delivered with precision. Ryne Bio aims to provide potent disease-modifying treatments for neurological disorders.
Contacts

Phone number

Social url

Similar Companies
999
AZTherapies

AZTherapies

AZTherapies is a clinical-stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Boston, MA, USA

total rounds

8

total raised

$99.84M
Alzamend Neuro

Alzamend Neuro

Alzamend Neuro is an innovative biotech company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Newport Beach, CA, USA

total rounds

1

total raised

$25M
ImStar Therapeutics

ImStar Therapeutics

ImStar Therapeutics develops treatments for amyotrophic lateral sclerosis patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Vancouver, BC, Canada

total rounds

5

total raised

$4.82M
NeuroGeneration

NeuroGeneration

Neurogeneration develops biological products from neural progenitor cells to treat aging and neurodegenerative disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Financials

Funding Rounds
3
3

Number of Funding Rounds

$89M

Money Raised

Their latest funding was raised on 29.02.2024. Their latest investor Alaska Permanent Fund. Their latest round Series A

Alaska Permanent Fund

Alaska Permanent Fund

The Alaska Permanent Fund Corporation manages a constitutionally established permanent fund in Alaska.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Juneau, AK, USA

total rounds

1

total raised

$100M

count Of Investments

15

count Of Exists

2
Cure Ventures

Cure Ventures

Cure Ventures invests in life sciences and medical technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Newport Beach, CA, USA

count Of Investments

2
The Column Group

The Column Group

The Column Group is a venture capital firm focused on creating the next generation of biotechnology companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Francisco, CA, USA

count Of Investments

95

count Of Exists

8
California Institute for Regenerative Medicine

California Institute for Regenerative Medicine

The California Institute for Regenerative Medicine supports stem cell research.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Francisco, CA, USA

count Of Investments

46

count Of Exists

1
Saisei Ventures

Saisei Ventures

Saisei Ventures is a leading venture capital firm focused on early-stage companies in the biotechnology sector.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology

Location

Cambridge, MA, USA

count Of Investments

6
Co-Investors
Investors
6
5

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Alaska Permanent Fund

Alaska Permanent Fund

The Alaska Permanent Fund Corporation manages a constitutionally established permanent fund in Alaska.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Juneau, AK, USA

total rounds

1

total raised

$100M

count Of Investments

15

count Of Exists

2
Cure Ventures

Cure Ventures

Cure Ventures invests in life sciences and medical technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Newport Beach, CA, USA

count Of Investments

2
Jeffrey Jonas

Jeffrey Jonas

Dr. Jeffrey Jonas served as Chief Executive Officer at ABIO-X. He served as Board Member at Angiocrine Bioscience. He also serves as Board Member at Noema Pharma.He also serves as Board Member at SAGE Therapeutics & Generation Bio. He serves as Chairman at Noema Pharma. He also served as President and Chief Executive Officer at SAGE Therapeutics. He also serves as Board Member at Decibel Therapeutics. He was most recently the President of Regenerative Medicine at Shire, brings more than 20 years of scientific and business leadership in the biotechnology and pharmaceutical industries, as well as a proven track record in developing and launching drugs for CNS diseases. Prior to Shire, he served as the Executive Vice President of ISIS Pharmaceuticals, as the Chief Medical Officer and Executive Vice President of Forest Laboratories, and in senior-level positions at Upjohn Laboratories. [Source: Public Company Filing]

David Fallace

David Fallace

Attributable venture investments at Alaska Permanent Fund include Juno Therapeutics. Attributable venture investments while at GF Private Equity Group include: Ahura (Acquired by Thermo Fisher Scientific Inc.), Teknovus (Acquired by Broadcom), Redline Communications (IPO), Kotura (Acquired by Mellanox), Veralight, Pathscale (Acquired by QLogic), Teros (Acquired by Citrx), Impinj, Applied Wave Research (Acquired by National Instruments), Venda and Pixtronix (Acquired by Qualcomm).

current job

TIFF Investment Management
TIFF Investment Management

Euclidean Capital

Euclidean Capital is an investment firm specializing in individual and family services management.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance

Location

New York, NY, USA

count Of Investments

35

count Of Exists

1

Activity

Recent News
0